{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:05:57Z","timestamp":1787785557529,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T00:00:00Z","timestamp":1420588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s11764-014-0419-6","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T05:12:46Z","timestamp":1420521166000},"page":"361-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study"],"prefix":"10.1007","volume":"9","author":[{"given":"Frances Josephine","family":"Drummond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Kinnear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"key":"419_CR1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220\u201341.","journal-title":"CA Cancer J Clin"},{"key":"419_CR2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/bjc.2012.366","volume":"107","author":"J Maddams","year":"2012","unstructured":"Maddams J, Utley M, M\u00f8ller H. Projections of cancer prevalence in the United Kingdom, 2010\u20132040. Br J Cancer. 2012;107:1195\u2013202.","journal-title":"Br J Cancer"},{"key":"419_CR3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.1995.03520310046028","volume":"273","author":"AL Potosky","year":"1995","unstructured":"Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995;273:548\u201352.","journal-title":"JAMA"},{"key":"419_CR4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","volume":"15","author":"R Angelis De","year":"2014","unstructured":"De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5\u2014a population-bases study. Lancet Oncol. 2014;15:23\u201334.","journal-title":"Lancet Oncol"},{"key":"419_CR5","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","volume":"370","author":"A Bill-Axelson","year":"2014","unstructured":"Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370:932\u2013342.","journal-title":"N Engl J Med"},{"key":"419_CR6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","volume":"367","author":"TJ Wilt","year":"2012","unstructured":"Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367:203\u201321.","journal-title":"N Engl J Med"},{"key":"419_CR7","doi-asserted-by":"crossref","first-page":"g1502","DOI":"10.1136\/bmj.g1502","volume":"348","author":"P Sooriakumaran","year":"2014","unstructured":"Sooriakumaran P, Nyberg T, Akre O, Haendler L, Heus I, Olsson M, et al. Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ. 2014;348:g1502.","journal-title":"BMJ"},{"issue":"5 Suppl","key":"419_CR8","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.urology.2009.03.003","volume":"73","author":"LG Gomella","year":"2009","unstructured":"Gomella LG, Johannes J, Trabulsi EJ. Current prostate cancer treatments: effect on quality of life. Urology. 2009;73(5 Suppl):S28\u201335.","journal-title":"Urology"},{"key":"419_CR9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/jnci\/djp114","volume":"101","author":"JL Gore","year":"2009","unstructured":"Gore JL, Kwan L, Lee SP, Reiter RE, Litwin MS. Survivorship beyond convalescence: 48-month quality of life outcomes after treatment for localized prostate cancer. J Natl Cancer Inst. 2009;101:888\u201392.","journal-title":"J Natl Cancer Inst"},{"key":"419_CR10","doi-asserted-by":"crossref","first-page":"b4817","DOI":"10.1136\/bmj.b4817","volume":"339","author":"DP Smith","year":"2009","unstructured":"Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P, et al. Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ. 2009;339:b4817.","journal-title":"BMJ"},{"key":"419_CR11","first-page":"S1","volume":"21","author":"FJ Drummond","year":"2013","unstructured":"Drummond FJ, Kinnear H, O\u2019Leary E, Gavin A, Sharp L. An all-Ireland population-based study of immediate and current physical and psychological side-effects of prostate cancer treatments. Support Care Cancer. 2013;21:S1\u2013S301.","journal-title":"Support Care Cancer"},{"key":"419_CR12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","volume":"358","author":"MG Sanda","year":"2008","unstructured":"Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250\u201361.","journal-title":"N Engl J Med"},{"key":"419_CR13","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/bjc.2013.181","volume":"108","author":"JJ Tol-Geerdink van","year":"2013","unstructured":"van Tol-Geerdink JJ, Leer JW, van Oort IM, van Lin EJ, Weijerman PC, Vergunst H, et al. Quality of life after prostate cancer treatments in patients comparable at baseline. Br J Cancer. 2013;108:1784\u20139.","journal-title":"Br J Cancer"},{"key":"419_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2013.05.038","volume":"108","author":"M Ferrer","year":"2013","unstructured":"Ferrer M, Guedea F, Su\u00e1rez JF, de Paula B, Mac\u00edas V, Mari\u00f1o A, et al. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5\u00a0year follow-up. Radiother Oncol. 2013;108:306\u201313.","journal-title":"Radiother Oncol"},{"key":"419_CR15","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1470-2045(11)70162-0","volume":"12","author":"E Johansson","year":"2011","unstructured":"Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Ruutu M, et al. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011;12:891\u20139.","journal-title":"Lancet Oncol"},{"key":"419_CR16","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/cncr.22231","volume":"107","author":"F Mols","year":"2006","unstructured":"Mols F, van de Poll-Franse LV, Vingerhoets AJ, Hendrikx A, Aaronson NK, Houterman S, et al. Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer. 2006;107:2186\u201396.","journal-title":"Cancer"},{"key":"419_CR17","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","volume":"23","author":"DC Miller","year":"2005","unstructured":"Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23:2772\u201380.","journal-title":"J Clin Oncol"},{"key":"419_CR18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ijc.21043","volume":"116","author":"IJ Korfage","year":"2005","unstructured":"Korfage IJ, Essink-Bot ML, Borsboom GJ, Madalinska JB, Kirkels WJ, Habbema JD, et al. Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer. 2005;116:291\u20136.","journal-title":"Int J Cancer"},{"key":"419_CR19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0360-3016(00)01365-1","volume":"49","author":"AL Hanlon","year":"2001","unstructured":"Hanlon AL, Watkins Bruner D, Peter R, Hanks GE. Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. Int J Radiat Oncol Biol Phys. 2001;49:51\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"419_CR20","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jpainsymman.2011.04.023","volume":"43","author":"AC Zucca","year":"2012","unstructured":"Zucca AC, Boyes AW, Linden W, Girgis A. All\u2019s well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types. J Pain Symptom Manage. 2012;43:720\u201331.","journal-title":"J Pain Symptom Manage"},{"key":"419_CR21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0360-3016(99)00496-4","volume":"46","author":"PA Johnstone","year":"2000","unstructured":"Johnstone PA, Gray C, Powell CR. Quality of life in T1-3N0 prostate cancer patients treated with radiation therapy with minimum 10-year follow-up. Int J Radiat Oncol Biol Phys. 2000;46:833\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"419_CR22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1464-410X.2009.08815.x","volume":"105","author":"MS Thong","year":"2010","unstructured":"Thong MS, Mols F, Kil PJ, Korfage IJ, van de Poll-Franse LV. Prostate cancer survivors who would be eligible for active surveillance but were either treated with radiotherapy or managed expectantly: comparisons on long-term quality of life and symptom burden. BJU Int. 2010;105:652\u20138.","journal-title":"BJU Int"},{"key":"419_CR23","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa021483","volume":"347","author":"G Steineck","year":"2002","unstructured":"Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norl\u00e9n BJ, et al. Scandinavian Prostatic Cancer Group Study Number 4. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790\u20136.","journal-title":"N Engl J Med"},{"key":"419_CR24","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.juro.2011.06.058","volume":"186","author":"JL Kasperzyk","year":"2011","unstructured":"Kasperzyk JL, Shappley 3rd WV, Kenfield SA, Mucci LA, Kurth T, Ma J, et al. Watchful waiting and quality of life among prostate cancer survivors in the Physicians\u2019 Health Study. J Urol. 2011;186:1862\u20137.","journal-title":"J Urol"},{"key":"419_CR25","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/cncr.22676","volume":"109","author":"MS Litwin","year":"2007","unstructured":"Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer. 2007;109:2239\u201347.","journal-title":"Cancer"},{"key":"419_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"419_CR27","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ejca.2008.07.030","volume":"44","author":"G Andel van","year":"2008","unstructured":"van Andel G, Bottomley A, Foss\u00e5 SD, Efficace F, Coens C, Guerif S, et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44:2418\u201324.","journal-title":"Eur J Cancer"},{"key":"419_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139\u201344.","journal-title":"J Clin Oncol"},{"key":"419_CR29","unstructured":"WMA declaration of Helsinki\u2014ethical principles for medical research involving human subjects. (2008). http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/17c.pdf . Accessed 9 July 2014."},{"key":"419_CR30","unstructured":"American Cancer Society. Cancer facts and figures 2000 (2000) Atlanta: Am Cancer Soc. Accessed 22 Jan 2013."},{"key":"419_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.radonc.2013.05.038","volume":"108","author":"M Ferrer","year":"2013","unstructured":"Ferrer M, Guedea F, Su\u00e1rez JF, de Paula B, Mac\u00edas V, Mari\u00f1o A, et al. Quality of life impact of treatments for localized prostate cancer: cohort study with a 5\u00a0year follow-up. Radiother Oncol. 2013;108:306\u201331.","journal-title":"Radiother Oncol"},{"key":"419_CR32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/bjc.2013.268","volume":"109","author":"CM Camargo de","year":"2013","unstructured":"de Camargo CM, Comber H, Sharp L. Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study. Br J Cancer. 2013;109:272\u20139.","journal-title":"Br J Cancer"},{"key":"419_CR33","author":"M Schmidt-Hansen","year":"2014","unstructured":"Schmidt-Hansen M, Hoskin P, Kirkbride P, Hasler E, Bromham N. Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses. Clin Oncol (R Coll Radiol). 2014. doi: 10.1016\/j.clon.2014.06.016 .","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"419_CR34","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0277-9536(99)00045-3","volume":"48","author":"MA Sprangers","year":"1999","unstructured":"Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48:1507\u201315.","journal-title":"Soc Sci Med"},{"key":"419_CR35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ejca.2005.11.026","volume":"42","author":"G Prue","year":"2006","unstructured":"Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer. 2006;42:846\u201363.","journal-title":"Eur J Cancer"},{"key":"419_CR36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/pon.3150","volume":"22","author":"J Savard","year":"2013","unstructured":"Savard J, Hervouet S, Ivers H. Prostate cancer treatments and their side effects are associated with increased insomnia. Psychooncology. 2013;22:1381\u20138.","journal-title":"Psychooncology"},{"key":"419_CR37","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00520-013-1751-5","volume":"21","author":"B Langston","year":"2013","unstructured":"Langston B, Armes J, Levy A, Tidey E, Ream E. The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature. Support Care Cancer. 2013;21:1761\u201371.","journal-title":"Support Care Cancer"},{"key":"419_CR38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.eururo.2013.09.051","volume":"65","author":"F Montorsi","year":"2014","unstructured":"Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, et al. Effects of tadalafil treatment of erectile function recovery following bilateral nerve sparing radical prostatectomy. A randomised placebo-controlled study (REACTT). Eur Urol. 2014;65:587\u201396.","journal-title":"Eur Urol"},{"key":"419_CR39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrurol.2013.206","volume":"10","author":"P Cormie","year":"2013","unstructured":"Cormie P, Newton RU, Taaffee DR, Spry N, Galvao DA. Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol. 2013;10:731\u20136.","journal-title":"Nat Rev Urol"},{"key":"419_CR40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00520-011-1271-0","volume":"20","author":"FT Baumann","year":"2012","unstructured":"Baumann FT, Zopf EM, Bloch W. Clinical exercise interventions in prostate cancer patients\u2014a systematic review of randomised controlled trials. Support Care Cancer. 2012;20:221\u201333.","journal-title":"Support Care Cancer"},{"key":"419_CR41","author":"D Larkin","year":"2013","unstructured":"Larkin D, Lopez V, Aromataris E. Managing cancer-related fatigue in men with prostate cancer: a systematic review of non-pharmacological interventions. Int J Nurs Pract. 2013. doi: 10.1111\/ijn.12211 .","journal-title":"Int J Nurs Pract"},{"key":"419_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-007-9602-z","volume":"108","author":"HM Milne","year":"2008","unstructured":"Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2008;108:279\u201388.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-014-0419-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-014-0419-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-014-0419-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T04:21:18Z","timestamp":1566188478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-014-0419-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1007\/s11764-014-0419-6","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,7]]}}}